Search

Carol M. Koslow

Examiner (ID: 12920, Phone: (571)272-1371 , Office: P/1734 )

Most Active Art Unit
1734
Art Unit(s)
1734, 1754, 1793, 1755, 1108
Total Applications
5011
Issued Applications
4022
Pending Applications
258
Abandoned Applications
784

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20005947 [patent_doc_number] => 20250144169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-08 [patent_title] => iRGD-ANALOGS AND RELATED THERAPEUTIC METHODS [patent_app_type] => utility [patent_app_number] => 19/018888 [patent_app_country] => US [patent_app_date] => 2025-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4808 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19018888 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/018888
iRGD-ANALOGS AND RELATED THERAPEUTIC METHODS Jan 12, 2025 Pending
Array ( [id] => 19658402 [patent_doc_number] => 20240425467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-26 [patent_title] => REAGENTS AND METHODS FOR BIOORTHOGONAL LABELING OF BIOMOLECULES IN LIVING CELLS [patent_app_type] => utility [patent_app_number] => 18/815249 [patent_app_country] => US [patent_app_date] => 2024-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19209 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18815249 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/815249
REAGENTS AND METHODS FOR BIOORTHOGONAL LABELING OF BIOMOLECULES IN LIVING CELLS Aug 25, 2024 Pending
Array ( [id] => 19570384 [patent_doc_number] => 20240374676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 [patent_app_type] => utility [patent_app_number] => 18/783777 [patent_app_country] => US [patent_app_date] => 2024-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22057 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18783777 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/783777
METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 Jul 24, 2024 Abandoned
Array ( [id] => 19570382 [patent_doc_number] => 20240374674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 [patent_app_type] => utility [patent_app_number] => 18/783556 [patent_app_country] => US [patent_app_date] => 2024-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22072 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18783556 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/783556
METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 Jul 24, 2024 Abandoned
Array ( [id] => 19570383 [patent_doc_number] => 20240374675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 [patent_app_type] => utility [patent_app_number] => 18/783572 [patent_app_country] => US [patent_app_date] => 2024-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22040 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18783572 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/783572
METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 Jul 24, 2024 Pending
Array ( [id] => 19554918 [patent_doc_number] => 20240366710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 [patent_app_type] => utility [patent_app_number] => 18/783546 [patent_app_country] => US [patent_app_date] => 2024-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22073 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18783546 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/783546
METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 Jul 24, 2024 Pending
Array ( [id] => 19541787 [patent_doc_number] => 20240358823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => CONJUGATED VACCINE CARRIER PROTEINS [patent_app_type] => utility [patent_app_number] => 18/434318 [patent_app_country] => US [patent_app_date] => 2024-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 94550 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18434318 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/434318
CONJUGATED VACCINE CARRIER PROTEINS Feb 5, 2024 Pending
Array ( [id] => 19316824 [patent_doc_number] => 20240238364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-18 [patent_title] => METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 [patent_app_type] => utility [patent_app_number] => 18/431587 [patent_app_country] => US [patent_app_date] => 2024-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21962 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18431587 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/431587
METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 Feb 1, 2024 Pending
Array ( [id] => 19345217 [patent_doc_number] => 20240254180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-01 [patent_title] => COMPOSITIONS OF PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR [patent_app_type] => utility [patent_app_number] => 18/422878 [patent_app_country] => US [patent_app_date] => 2024-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36097 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18422878 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/422878
COMPOSITIONS OF PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Jan 24, 2024 Pending
Array ( [id] => 20023248 [patent_doc_number] => 20250161470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-22 [patent_title] => MITOCHONDRIAL INTERVENTION IN NEUROLOGICAL DISORDERS [patent_app_type] => utility [patent_app_number] => 18/413733 [patent_app_country] => US [patent_app_date] => 2024-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18413733 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/413733
MITOCHONDRIAL INTERVENTION IN NEUROLOGICAL DISORDERS Jan 15, 2024 Pending
Array ( [id] => 19543151 [patent_doc_number] => 20240360187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => NANOSPHERES OF SEC14-LIKE PROTEINS AND COGNATE LIGANDS [patent_app_type] => utility [patent_app_number] => 18/545392 [patent_app_country] => US [patent_app_date] => 2023-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17972 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18545392 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/545392
NANOSPHERES OF SEC14-LIKE PROTEINS AND COGNATE LIGANDS Dec 18, 2023 Pending
Array ( [id] => 19496530 [patent_doc_number] => 20240335548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-10 [patent_title] => MACROMOLECULES [patent_app_type] => utility [patent_app_number] => 18/507435 [patent_app_country] => US [patent_app_date] => 2023-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35423 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18507435 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/507435
MACROMOLECULES Nov 12, 2023 Abandoned
Array ( [id] => 19216293 [patent_doc_number] => 20240180997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-06 [patent_title] => PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES [patent_app_type] => utility [patent_app_number] => 18/386971 [patent_app_country] => US [patent_app_date] => 2023-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27134 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18386971 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/386971
PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES Nov 2, 2023 Abandoned
Array ( [id] => 19201517 [patent_doc_number] => 20240173416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-30 [patent_title] => PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDE CONJUGATES AND METHODS OF USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/501061 [patent_app_country] => US [patent_app_date] => 2023-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31859 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18501061 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/501061
PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDE CONJUGATES AND METHODS OF USES THEREOF Nov 2, 2023 Pending
Array ( [id] => 18953653 [patent_doc_number] => 20240041980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING TYPE 2 DIABETES USING GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) [patent_app_type] => utility [patent_app_number] => 18/238261 [patent_app_country] => US [patent_app_date] => 2023-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11362 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18238261 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/238261
COMPOSITIONS AND METHODS FOR TREATING TYPE 2 DIABETES USING GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) Aug 24, 2023 Pending
Array ( [id] => 19201485 [patent_doc_number] => 20240173384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-30 [patent_title] => TREATMENT OF PEDIATRIC TYPE 2 DIABETES MELLITUS PATIENTS [patent_app_type] => utility [patent_app_number] => 18/366130 [patent_app_country] => US [patent_app_date] => 2023-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7666 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18366130 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/366130
TREATMENT OF PEDIATRIC TYPE 2 DIABETES MELLITUS PATIENTS Aug 6, 2023 Abandoned
Array ( [id] => 18895188 [patent_doc_number] => 20240010673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => GENETICALLY ENGINEERED RECOMBINANT PROTEINS FOR FUNCTIONAL REGENERATIVE TISSUE SCAFFOLDS [patent_app_type] => utility [patent_app_number] => 18/365648 [patent_app_country] => US [patent_app_date] => 2023-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14315 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18365648 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/365648
GENETICALLY ENGINEERED RECOMBINANT PROTEINS FOR FUNCTIONAL REGENERATIVE TISSUE SCAFFOLDS Aug 3, 2023 Pending
Array ( [id] => 19127193 [patent_doc_number] => 20240132546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-25 [patent_title] => CHARGE MODIFIED DESIGNED REPEAT DOMAINS AND THEIR USE [patent_app_type] => utility [patent_app_number] => 18/362079 [patent_app_country] => US [patent_app_date] => 2023-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55633 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18362079 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/362079
CHARGE MODIFIED DESIGNED REPEAT DOMAINS AND THEIR USE Jul 30, 2023 Pending
Array ( [id] => 19127193 [patent_doc_number] => 20240132546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-25 [patent_title] => CHARGE MODIFIED DESIGNED REPEAT DOMAINS AND THEIR USE [patent_app_type] => utility [patent_app_number] => 18/362079 [patent_app_country] => US [patent_app_date] => 2023-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55633 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18362079 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/362079
CHARGE MODIFIED DESIGNED REPEAT DOMAINS AND THEIR USE Jul 29, 2023 Pending
Array ( [id] => 19112792 [patent_doc_number] => 20240124542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-18 [patent_title] => GDF11 VARIANTS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/227540 [patent_app_country] => US [patent_app_date] => 2023-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32884 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18227540 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/227540
GDF11 VARIANTS AND USES THEREOF Jul 27, 2023 Pending
Menu